Articles with "novel reversible" as a keyword



Photo from wikipedia

Identification and characterization of the novel reversible and selective cathepsin X inhibitors

Sign Up to like & get
recommendations!
Published in 2017 at "Scientific Reports"

DOI: 10.1038/s41598-017-11935-1

Abstract: Cathepsin X is a cysteine peptidase involved in the progression of cancer and neurodegenerative diseases. Targeting this enzyme with selective inhibitors opens a new possibility for intervention in several therapeutic areas. In this study triazole-based… read more here.

Keywords: characterization novel; reversible selective; cathepsin; novel reversible ... See more keywords
Photo from wikipedia

Structural basis for the inhibitory effects of a novel reversible covalent ligand on PPARγ phosphorylation

Sign Up to like & get
recommendations!
Published in 2019 at "Scientific Reports"

DOI: 10.1038/s41598-019-47672-w

Abstract: Peroxisome proliferator-activated receptor γ (PPARγ) is a major therapeutic target for the treatment of type 2 diabetes. However, the use of PPARγ-targeted drugs, such as rosiglitazone and pioglitazone, is limited owing to serious side effects… read more here.

Keywords: ppar; ppar phosphorylation; novel reversible; phosphorylation ... See more keywords

A novel reversible fluorescent probe for Cu2+ and S2− ions and imaging in living cells

Sign Up to like & get
recommendations!
Published in 2022 at "Methods and Applications in Fluorescence"

DOI: 10.1088/2050-6120/ac719a

Abstract: A novel fluorescent probe TSOC (thiazole salicylaldehyde oxazole chlorinated) was synthesized based on benzothiazole conjugated olefinic bonds with salicylicaldehyde unit as fluorophore and a phenyl oxazole unit as bonding unit. The probe could reversibly detect… read more here.

Keywords: cu2; living cells; fluorescent probe; novel reversible ... See more keywords

Abstract 4871: Antitumor activity of novel reversible LSD1 inhibitor, HM97211 in preclinical models of SCLC

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Research"

DOI: 10.1158/1538-7445.am2018-4871

Abstract: Introduction: Global changes in the epigenetic landscape are known as the hallmark in cancer and the histone demethylase Lysine-specific demethylase 1 (LSD1) is one of the novel target for the therapy of various malignant diseases… read more here.

Keywords: inhibitor hm97211; lsd1 inhibitor; reversible lsd1; novel reversible ... See more keywords